Sequencing is the future of the treatment for multiple myeloma. An approach that places therapy in a continuous and sequential vision, enhancing collaboration and interaction between doctor and patient.

We have transformed Sequencing into an actual series

that connects scientific evidence to real life: THE SEQUENCE.

A sequential story in three episodes, staged on a real set,

in which the clinical sessions on Multiple Myeloma addressed by 17 KOL are intertwined in the script with the human stories of three members of the crew, who find new answers to the condition of their loved ones.

Each episode can be viewed on demand, in sequence, from a digital platform with regulated access, with participant tracking and viewers count - integrated with surveys to monitor feedback and satisfaction.

It was necessary to find an innovative way to create a virtual event capable of engaging all the Italian onco-hematologists, and to convey the energy and empathy of Sequencing

Therapeuthic sequencing has been transformed into a four-episodes serie that connects clinical evidence to real life experience.

The Sequence is a promotional event recorded in a production studio: four episodes dedicated to the management of Multiple Myeloma and therapeutic sequencing.

We have imagined a real life story on set in which three sequencing moments interwine with human stories of three members of the troupe.

During the Event, clinicians involved in Round Tables/episodes discuss about innovations in multiple myeloma:

1. lenalidomide

2. diagnosis

3. combination of pomalidomide, bortezomib and dexamethasone (PVd) in second line

4. new combination of elotuzumab with pomalidomide and dexamethasone (EPd) in the third line

Scientific discussions become a fictional narrative that offer a different perspective showing the caregivers and patients life.

Quantitatives KPIs

80% of clinicians who expressed interest on the project attended the event

Qualitative KPIs

100% of the users (hematologists) are fullfilled on the contents